169 related articles for article (PubMed ID: 25400738)
21. Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery.
Ikoma N; Torres KE; Lin HY; Ravi V; Roland CL; Mann GN; Hunt KK; Cormier JN; Feig BW
J Surg Oncol; 2017 Sep; 116(3):313-319. PubMed ID: 28557016
[TBL] [Abstract][Full Text] [Related]
22. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas.
Shpitz B; Tiomkin V; Bomstein Y; Gralkin M; Buklan H; Bernheim J; Klein E
Eur J Surg Oncol; 2001 Mar; 27(2):203-8. PubMed ID: 11289760
[TBL] [Abstract][Full Text] [Related]
24. A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular data.
Würl P; Lautenschläger C; Meye A; Schmidt H; Bache M; Rath FW; Schönfelder M; Taubert H
Anticancer Res; 2000; 20(3B):2065-72. PubMed ID: 10928153
[TBL] [Abstract][Full Text] [Related]
25. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
26. Differentiation, proliferation and apoptosis levels in human leiomyoma and leiomyosarcoma.
Valenti MT; Azzarello G; Vinante O; Manconi R; Balducci E; Guidolin D; Chiavegato A; Sartore S
J Cancer Res Clin Oncol; 1998; 124(2):93-105. PubMed ID: 9654192
[TBL] [Abstract][Full Text] [Related]
27. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
Sun M; Liu JG; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
[No Abstract] [Full Text] [Related]
28. Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.
Espinosa I; Beck AH; Lee CH; Zhu S; Montgomery KD; Marinelli RJ; Ganjoo KN; Nielsen TO; Gilks CB; West RB; van de Rijn M
Am J Pathol; 2009 Jun; 174(6):2347-56. PubMed ID: 19443701
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic factors predicting postoperative survival period in the treatment of primary retroperitoneal leiomyosarcoma].
Zhao XD; Li PY; Huang XH; Chen L; Li R; Liu N
Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):891-4. PubMed ID: 24433766
[TBL] [Abstract][Full Text] [Related]
30. Retroperitoneal Sarcomas: Does Laterality Matter?
Lou J; Moten AS; Reddy SS; Howell KJ; Movva S; von Mehren M; Farma JM
J Surg Res; 2019 Dec; 244():34-41. PubMed ID: 31279261
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
32. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ
Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902
[TBL] [Abstract][Full Text] [Related]
33. Metastatic leiomyosarcoma in the oral cavity: case report with protein expression profiles.
Kim SM; Myoung H; Choung PH; Kim MJ; Lee SK; Lee JH
J Craniomaxillofac Surg; 2009 Dec; 37(8):454-60. PubMed ID: 19664933
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of CREPT confers colorectal cancer sensitivity to fluorouracil.
Kuang YS; Wang Y; Ding LD; Yang L; Wang Y; Liu SH; Zhu BT; Wang XN; Liu HY; Li J; Chang ZJ; Wang YY; Jia BQ
World J Gastroenterol; 2018 Jan; 24(4):475-483. PubMed ID: 29398868
[TBL] [Abstract][Full Text] [Related]
35. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
[TBL] [Abstract][Full Text] [Related]
36. Leiomyosarcoma: a 45-year review at Charity Hospital, New Orleans.
Hill MA; Mera R; Levine EA
Am Surg; 1998 Jan; 64(1):53-60; discussion 60-1. PubMed ID: 9457038
[TBL] [Abstract][Full Text] [Related]
37. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
Binh MB; Guillou L; Hostein I; Château MC; Collin F; Aurias A; Binh BN; Stoeckle E; Coindre JM
Am J Surg Pathol; 2007 Oct; 31(10):1557-66. PubMed ID: 17895758
[TBL] [Abstract][Full Text] [Related]
38. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
Amada S; Nakano H; Tsuneyoshi M
Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
[TBL] [Abstract][Full Text] [Related]
39. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
40. Outcome of iliocaval resection and reconstruction for retroperitoneal sarcoma.
Ferraris M; Callegaro D; Barretta F; Fiore M; Radaelli S; Stacchiotti S; Miceli R; Socrate AM; Locati P; Gronchi A
J Vasc Surg Venous Lymphat Disord; 2019 Jul; 7(4):547-556. PubMed ID: 30792153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
